157 related articles for article (PubMed ID: 31990743)
1. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
Chang M; Dalvin LA; Mazloumi M; Martin A; Yaghy A; Yang X; Bakhtiari S; Li L; Jennings E; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(1):29-38. PubMed ID: 31990743
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma.
Shah SU; Shields CL; Bianciotto CG; Iturralde J; Al-Dahmash SA; Say EAT; Badal J; Mashayekhi A; Shields JA
Ophthalmology; 2014 Jan; 121(1):269-275. PubMed ID: 24139123
[TBL] [Abstract][Full Text] [Related]
3. Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals.
Shields CL; Dalvin LA; Chang M; Mazloumi M; Fortin P; McGarrey M; Martin A; Yaghy A; Yang X; Vichitvejpaisal P; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2020 Feb; 138(2):136-146. PubMed ID: 31830238
[TBL] [Abstract][Full Text] [Related]
4. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.
Finger PT; Chin KJ; Semenova EA
Eur J Ophthalmol; 2016; 26(1):60-6. PubMed ID: 26391167
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
7. Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients.
Dalvin LA; Zhang Q; Hamershock RA; Chang M; Yu MD; Mashayekhi A; Shields CL
Br J Ophthalmol; 2020 May; 104(5):697-702. PubMed ID: 31409650
[TBL] [Abstract][Full Text] [Related]
8. Impact of uveal melanoma thickness on post-plaque radiotherapy outcomes in the prophylactic anti-vascular endothelial growth factor era in 1131 patients.
Yang X; Dalvin LA; Mazloumi M; Chang M; Shields JA; Mashayekhi A; Shields CL
Clin Exp Ophthalmol; 2020 Jul; 48(5):610-623. PubMed ID: 32277560
[TBL] [Abstract][Full Text] [Related]
9. RETINAL MICROVASCULAR CHANGES IN UVEAL MELANOMA FOLLOWING CONBERCEPT INJECTION AFTER PLAQUE RADIOTHERAPY AS DETECTED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Yang JY; Wang Q; Chen MX; Yan YN; Zhou WJ; Liu YM; Wei WB
Retina; 2021 Dec; 41(12):2605-2611. PubMed ID: 34155168
[TBL] [Abstract][Full Text] [Related]
10. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
Daruich A; Matet A; Schalenbourg A; Zografos L
Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
[TBL] [Abstract][Full Text] [Related]
11. Aflibercept for Radiation Maculopathy Study: A Prospective, Randomized Clinical Study.
Murray TG; Latiff A; Villegas VM; Gold AS
Ophthalmol Retina; 2019 Jul; 3(7):561-566. PubMed ID: 31277797
[TBL] [Abstract][Full Text] [Related]
12. Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin).
Gupta A; Muecke JS
Retina; 2008; 28(7):964-8. PubMed ID: 18698298
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
Seibel I; Hager A; Riechardt AI; Davids AM; Böker A; Joussen AM
Am J Ophthalmol; 2016 Aug; 168():31-39. PubMed ID: 27163234
[TBL] [Abstract][Full Text] [Related]
14. Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes.
Schefler AC; Fuller D; Anand R; Fuller T; Moore C; Munoz J; Kim RS;
Am J Ophthalmol; 2020 Aug; 216():165-173. PubMed ID: 32278771
[TBL] [Abstract][Full Text] [Related]
15. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
16. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Kaplan RI; Chaugule SS; Finger PT
Br J Ophthalmol; 2017 Dec; 101(12):1694-1698. PubMed ID: 28416492
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma.
Mason JO; Albert MA; Persaud TO; Vail RS
Retina; 2007 Sep; 27(7):903-7. PubMed ID: 17891015
[TBL] [Abstract][Full Text] [Related]
19. Radiation maculopathy treated with intravitreal bevacizumab.
Sánchez-Vicente JL; Muñoz-Morales A; Galván-Carrasco MP; Castilla-Lázpita A; Vital-Berral C; Alfaro-Juárez A; Rueda-Rueda T
Arch Soc Esp Oftalmol; 2017 Jun; 92(6):283-286. PubMed ID: 27894518
[TBL] [Abstract][Full Text] [Related]
20. Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial.
Horgan N; Shields CL; Mashayekhi A; Salazar PF; Materin MA; O'Regan M; Shields JA
Ophthalmology; 2009 Jul; 116(7):1383-90. PubMed ID: 19481812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
